Login to Your Account



Other News To Note


Wednesday, May 11, 2011
Paladin Labs Inc., of Montreal, granted Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, an exclusive right to develop and commercialize fomepizole (marketed as Antizol in Canada and the U.S.) for the treatment of ethylene glycol and methanol poisonings in Japan.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription